Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Gross Margin (2021 - 2025)

Historic Gross Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 224.42%.

  • Pulse Biosciences' Gross Margin changed N/A to 224.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 224.42%, marking a year-over-year change of. This contributed to the annual value of 1606.29% for FY2022, which is 15675000.0% down from last year.
  • As of Q3 2025, Pulse Biosciences' Gross Margin stood at 224.42%.
  • Pulse Biosciences' 5-year Gross Margin high stood at 14444.44% for Q4 2022, and its period low was 348.0% during Q2 2022.
  • Moreover, its 3-year median value for Gross Margin was 75.88% (2021), whereas its average is 2282.27%.
  • Over the last 5 years, Pulse Biosciences' Gross Margin had its largest YoY gain of 144914800bps in 2022, and its largest YoY loss of 144914800bps in 2022.
  • Pulse Biosciences' Gross Margin (Quarter) stood at 47.04% in 2021, then soared by 30808bps to 14444.44% in 2022, then plummeted by -102bps to 224.42% in 2025.
  • Its Gross Margin was 224.42% in Q3 2025, compared to 14444.44% in Q4 2022 and 348.0% in Q2 2022.